Evidence map›Paper›PMID 33352854›Full record

ArticleInternational journal of molecular sciences2020

Dimethyl Fumarate Attenuates Lung Inflammation and Oxidative Stress Induced by Chronic Exposure to Diesel Exhaust Particles in Mice.

Isabella Cattani-Cavalieri, Helber da Maia Valença, João Alfredo Moraes, Lycia Brito-Gitirana, Bruna Romana-Souza, Martina Schmidt, Samuel Santos Valença

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Senotherapy for chronic lung disease.Pharmacological reviews · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Isabella Cattani-CavalieriInstitute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro 21044-020, Brazil.
Helber da Maia ValençaInstitute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro 21044-020, Brazil.ORCID 0000-0003-1965-3362
João Alfredo MoraesInstitute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro 21044-020, Brazil.ORCID 0000-0002-8563-6432
Lycia Brito-GitiranaInstitute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro 21044-020, Brazil.ORCID 0000-0002-5580-6939
Bruna Romana-SouzaDepartment of Histology and Embryology, Rio de Janeiro State University, Rio de Janeiro 20943-000, Brazil.ORCID 0000-0001-5665-8694
Martina SchmidtUniversity Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, 9700 Groningen, The Netherlands.ORCID 0000-0003-3075-0630
Samuel Santos ValençaDepartment of Histology and Embryology, Rio de Janeiro State University, Rio de Janeiro 20943-000, Brazil.
Universidade Federal do Rio de Janeiro · BRUniversidade do Estado do Rio de Janeiro · BRUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Air pollution is mainly caused by burning of fossil fuels, such as diesel, and is associated with increased morbidity and mortality due to adverse health effects induced by inflammation and oxidative stress. Dimethyl fumarate (DMF) is a fumaric acid ester and acts as an antioxidant and anti-inflammatory agent. We investigated the potential therapeutic effects of DMF on pulmonary damage caused by chronic exposure to diesel exhaust particles (DEPs). Mice were challenged with DEPs (30 μg per mice) by intranasal instillation for 60 consecutive days. After the first 30 days, the animals were treated daily with 30 mg/kg of DMF by gavage for the remainder of the experimental period. We demonstrated a reduction in total inflammatory cell number in the bronchoalveolar lavage (BAL) of mice subjected to DEP + DMF as compared to those exposed to DEPs alone. Importantly, DMF treatment was able to reduce lung injury caused by DEP exposure. Intracellular total reactive oxygen species (ROS), peroxynitrite (OONO), and nitric oxide (NO) levels were significantly lower in the DEP + DMF than in the DEP group. In addition, DMF treatment reduced the protein expression of kelch-like ECH-associated protein 1 (Keap-1) in lung lysates from DEP-exposed mice, whereas total nuclear factor κB (NF-κB) p65 expression was decreased below baseline in the DEP + DMF group compared to both the control and DEP groups. Lastly, DMF markedly reduced DEP-induced expression of nitrotyrosine, glutathione peroxidase-1/2 (Gpx-1/2), and catalase in mouse lungs. In summary, DMF treatment effectively reduced lung injury, inflammation, and oxidative and nitrosative stress induced by chronic DEP exposure. Consequently, it may lead to new therapies to diminish lung injury caused by air pollutants.

Indexed as

Oxidative StressVehicle EmissionsAir PollutantsAnimalsBiomarkersBronchoalveolar Lavage FluidCytokinesDimethyl FumarateDisease Models, AnimalInflammation MediatorsKelch-Like ECH-Associated Protein 1MiceNF-kappa BOxidation-ReductionPneumoniaReactive Nitrogen SpeciesAir PollutantsBiomarkersCytokinesDimethyl FumarateInflammation MediatorsKelch-Like ECH-Associated Protein 1NF-kappa BReactive Nitrogen SpeciesReactive Oxygen SpeciesVehicle Emissionsair pollutiondiesel exhaust particlesdimethyl fumarateinflammationlungmiceoxidative stress

Identifiers

PMID33352854
PMCPMC7767202
OpenAlexW3112946652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.